Member Profile Harpitdown | About

Recent Articles

Allogene Therapeutics Shares Key ASCO 2025 Abstracts on CAR T Developments
IMUNON Seeks to Withdraw Registration Amid Growth Plans
Abcourt Mines Inc. Reports Solid Third Quarter Progress
PDS Biotech Shares Positive Results for Versamune® HPV Treatments
Servotronics' Proxy Contest Conclusion and Upcoming Meeting
Haivision to Unveil Financial Insights for Q2 Fiscal 2025
M-tron Industries, Inc. Announces Upcoming Investor Meeting
Rigel Pharmaceuticals Set for Major Presentations at ASCO 2025
Investors Can Join Digimarc Corporation Class Action Today
ImCheck Therapeutics Showcases Promising AML Therapy Results
Legend Biotech Reveals Significant Updates in Cancer Treatment
ROHM Introduces Next-Gen Compact NIR LEDs for Advanced Applications
Cullinan Therapeutics and Partners Showcase Breakthrough Cancer Trial Findings
Biodesix Unveils Promising Data on VeriStrat Test for NSCLC
Acceleware Ltd. Achieves Significant Progress in Q1 2025
Genmab Unveils Late-Stage Data Ahead of ASCO 2025 Meeting
Petrus Resources Shares Success of Annual Meeting Outcomes
Exciting Phase 2 Results from Actuate's Elraglusib in Cancer Treatment
Candel Therapeutics Advances Localized Prostate Cancer Treatment
Adagene Showcases Promising Results for ADG126 in Cancer Trials
Banco Comercial Português Highlights Key AGM Resolutions
Wheaton Precious Metals Unveils 2024 Reports on Sustainability and Climate
Novita Reports Encouraging Phase 2 Trial Results for NP-G2-044
Accent Therapeutics Showcases Innovative Cancer Treatment Advances
Cizzle Bio's CIZ1B Test Offers Significant Medicare Savings
Ontario International Airport Sees Record Passenger Growth
Foresight Diagnostics Validates CLARITY MRD Assay for DLBCL
XTANDI™ Breakthrough: Prostate Cancer Patients See 30% Survival Increase
Servier Showcases Commitment to IDH-Mutated Cancer Research
West Fraser Timber's Commitment to Sustainability in 2024
Boehringer Ingelheim's Ambitious Plan for Future Cancer Innovations
Taiho Oncology Unveils Groundbreaking Cancer Therapy Data
Eli Lilly Unveils Research Presentations for ASCO 2025 Meeting
COOFANDY Celebrates a Decade of Excellence with Major Awards
Unlocking Earning Potential: FioBit's AI Mining Revolution 2025
Unlock Passive Income with PAIRMiner's Cutting-Edge Mining
THOR Industries Prepares for Upcoming Q3 2025 Earnings Call
Clear Blue Technologies Plans Corporate Update and Q1 2025 Report
Bicara Therapeutics Shares Key Data on Ficerafusp Alfa Therapy
Northview Residential REIT Declares Latest Distribution for Investors
Zymeworks Showcases Cancer Treatments at Major Medical Events
VCI Global's Equity Agreement Revamped for Strategic Growth
Innovative Treatment Combines Linvoseltamab with Proteasome Inhibitors
Stephen Brannan Joins Serina Therapeutics Board for Growth
Onconetix Inc. Faces Delisting Notice from Nasdaq Amid Compliance Issues
Cal Redwood Acquisition Corp. Successfully Prices $200 Million Offering
Gemspring Capital Expands Portfolio with Goodyear Chemical Acquisition
Life Time Eagle: A New Era for Health and Wellness In Idaho
RNR Tire Express Celebrates Community Impact and Awards
Southwest Airlines to Discuss Strategic Plans at Major Conference